Friday, July 11, 2014 Tammuz 13, 5774

Biotechnology Innovations on Tap for Health Care Audience

February 6, 2013
Comment0
Enlarge Image »
Dr. Steven Nichtberger.

Dr. Steven Nichtberger, president and CEO of Tengion, will speak about "Regenerative Human Organs and Tissues" on Monday, Nov. 8, 6:30 p.m., at Har Zion Temple, 1500 Hagys Ford Road, Penn Valley. The program, sponsored by the Jewish Federation of Greater Philadelphia's Health Care Affiliation, will kick off with a cocktail and networking reception.

Tengion is a clinical-stage biotechnology company that is focused on catalyzing the body's innate ability to regenerate diseased and failing organs and tissues.

According to Nichtberger, there is a critical need for this technology.

"There are currently 108,565 Americans on the donor organ waiting list, and if they are fortunate enough to find one, they will face a lifetime of treatment to suppress their immune systems to prevent rejection," he explains. "The unmet human need is staggering, and the cost to America for current treatments -- there are no cures -- has reached $100 billion a year according to a recent U.S. government report."

Nichtberger is a co-founder of the company, which was created in 2004.

Tengion was the world's first facility to grow human organs. In 2008 and 2009, it was recognized by The Scientist magazine as one of the top 10 health care companies to work for in the United States.

Nichtberger received the 2008 Ernst & Young National Entrepreneur of the Year award for his visionary leadership.

Prior to co-founding Tengion, Nichtberger was a member of the senior management team at Merck. He holds a B.A. in biology from the University of Pennsylvania, a B.S. in economics from the Wharton School, and an M.D. from the School of Medicine and Biosciences, SUNY at Buffalo.

He currently sits on the board of overseers of the University of Pennsylvania School of Arts and Sciences; the board of directors of the Biotechnology Industry Organization; the board of directors of Pennsylvania Bio, where he is chairman; the board of directors of BioAdvance; and the external advisory board of the Center for Bioethics at the University of Pennsylvania.

Federation's Health Care affiliation is open to men and women in the health care industries who would like to network with colleagues and explore connecting to the Greater Philadelphia Jewish community.

The cost to participate in the Nov. 8 program is $36 per person. Health Care Affiliation co-chairs are Bernie Dishler and Jeremy Goldberg. Sponsors for this event are Blank Rome LLP and El Al Airlines.

For questions about the event, call 215-832-0529. To register, log on to: www.jewishphilly.org/healthcare.


Comments on this Article

Sign up for our Newsletter

Advertisement